These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33278551)

  • 21. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
    Feng A; Tu Z; Yin B
    Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma.
    Luo S; Luo Y; Wang Z; Yin H; Wu Q; Du X; Xie X
    Cancer Lett; 2024 May; 589():216811. PubMed ID: 38490328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tsukushi is a novel prognostic biomarker and correlates with tumor-infiltrating B cells in non-small cell lung cancer.
    Huang H; Zhang D; Fu J; Zhao L; Li D; Sun H; Liu X; Xu J; Tian T; Zhang L; Liu Y; Zhang Y; Zhao Y
    Aging (Albany NY); 2021 Jan; 13(3):4428-4451. PubMed ID: 33428594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non-small cell lung cancer patients.
    Liao L; Yu H; Ge M; Zhan Q; Huang R; Ji X; Liang X; Zhou X
    Thorac Cancer; 2019 May; 10(5):1203-1212. PubMed ID: 30977310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model.
    He RQ; Li XJ; Liang L; Xie Y; Luo DZ; Ma J; Peng ZG; Hu XH; Chen G
    BMC Cancer; 2017 Sep; 17(1):655. PubMed ID: 28927388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Significance of miR-210 and its Prospective Signaling Pathways in Non-Small Cell Lung Cancer: Evidence from Gene Expression Omnibus and the Cancer Genome Atlas Data Mining with 2763 Samples and Validation via Real-Time Quantitative PCR.
    He RQ; Cen WL; Cen JM; Cen WN; Li JY; Li MW; Gan TQ; Hu XH; Chen G
    Cell Physiol Biochem; 2018; 46(3):925-952. PubMed ID: 29669324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer.
    Sun L; Yuan H; Burnett J; Gasparyan M; Zhang Y; Zhang F; Yang Z; Ran Y; Sun D
    Int J Med Sci; 2019; 16(1):68-74. PubMed ID: 30662330
    [No Abstract]   [Full Text] [Related]  

  • 30. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
    He W; Zhang H; Wang Y; Zhou Y; Luo Y; Cui Y; Jiang N; Jiang W; Wang H; Xu D; Li S; Wang Z; Chen Y; Sun Y; Zhang Y; Tseng HR; Zou X; Wang L; Ke Z
    BMC Cancer; 2018 Apr; 18(1):400. PubMed ID: 29631554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of miR-493-5p positively correlates with clinical prognosis of non small cell lung cancer by targeting oncogene ITGB1.
    Liang Z; Kong R; He Z; Lin LY; Qin SS; Chen CY; Xie ZQ; Yu F; Sun GQ; Li CG; Fu D; Jiang GX; Chen J; Ma YS
    Oncotarget; 2017 Jul; 8(29):47389-47399. PubMed ID: 28537888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma.
    Yang M; Feng Y; Yue C; Xu B; Chen L; Jiang J; Lu B; Zhu Y
    PLoS One; 2018; 13(3):e0193428. PubMed ID: 29499051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene co-expression modules integrated with immunoscore predicts survival of non-small cell lung cancer.
    Li XT; Zhang JT; Yan HH; Su J; Cheng ML; Sun QH; Zhong WZ; Wu YL; Zhang DX; Hou DJ
    Cancer Treat Res Commun; 2021; 26():100297. PubMed ID: 33385734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.
    Li Z; Qu L; Zhong H; Xu K; Qiu X; Wang E
    Oncol Rep; 2014 Apr; 31(4):1707-14. PubMed ID: 24573418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.
    Xie H; Xie C
    Biomed Res Int; 2019; 2019():4250613. PubMed ID: 31886214
    [No Abstract]   [Full Text] [Related]  

  • 37. SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer.
    Dai W; Feng J; Hu X; Chen Y; Gu Q; Gong W; Feng T; Wu J
    Cancer Cell Int; 2021 Feb; 21(1):106. PubMed ID: 33632211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
    Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
    Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y; Sun N; Lu Z; Sun S; Huang J; Chen Z; He J
    Cancer Lett; 2017 May; 393():40-51. PubMed ID: 28223168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.